Brief: Hoth Therapeutics Launches Expanded Access Initiative For HT-001
11/06/2025 14:04
June 11 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS LAUNCHES EXPANDED ACCESS INITIATIVE FOR HT-001, OFFERING CRITICAL RELIEF TO CANCER PATIENTS FACING SEVERE SKIN TOXICITIES Source text: ID:nPn6yXJyGa Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology